What is CVE-2023-43054?

CVE-2023-43054 is a medium-severity vulnerability in Ibm Engineering Test Management, classified under Cross-site Scripting. CVSS score: 6.4/10. Published 2024-03-03.

How severe is CVE-2023-43054?

Medium severity. CVSS v3 base score is 6.4 out of 10.

Is CVE-2023-43054 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

XSS in Ibm Engineering Test Management

CVE-2023-43054

IBM Engineering Test Management 7.0.2 and 7.0.3 is vulnerable to stored cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to…

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.001 (34.8th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.4 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:N.

Affected products

Ibm Engineering Test Management — versions 7.0.2, 7.0.3

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

Public proof-of-concept exploits

fkie-cad/nvd-json-data-feeds

References

www.ibm.com/support/pages/node/7122399 (vendor-advisory)
exchange.xforce.ibmcloud.com/vulnerabilities/267459

Frequently asked questions

What is CVE-2023-43054?: CVE-2023-43054 is a medium-severity vulnerability in Ibm Engineering Test Management, classified under Cross-site Scripting. CVSS score: 6.4/10. Published 2024-03-03.
How severe is CVE-2023-43054?: Medium severity. CVSS v3 base score is 6.4 out of 10.
Is CVE-2023-43054 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.